NKF K/DOQI GUIDELINES 2000
 
 

THE NKF-K/DOQI HEMODIALYSIS ADEQUACY WORK GROUP MEMBERS

GUIDELINES FOR HEMODIALYSIS ADEQUACY

IX. Biographical Sketches of the NKF-K/DOQI Hemodialysis Adequacy Work Group Members

The following are brief sketches that describe the professional training and experience, as well as principal business affiliations of the Work Group members. All Work Group members completed a disclosure statement certifying that any potential conflict of interest would not influence their judgment or actions concerning the NKF-K/DOQI.

William Owen, Jr., MD (Work Group Chair), is the Director of Duke Institute of Renal Outcomes Research and Health Policy at the Duke University Medical Center in Durham, North Carolina, and an Associate Professor of Medicine with tenure at Duke University School of Medicine. Dr. Owen’s professional career has focused on developing process measures of outcome for patients with end-stage renal disease (ESRD) and on broadening the tools for dialysis care teams to monitor relevant processes of patient care. Dr. Owen is the President-Elect of the Renal Physicians Association (RPA), a Scientific Councilor for the Warren Magnuson Clinical Center of the National Institutes of Health, a Director of the RPA/ Renal Education Foundation, a member of the Health Care Financing Administration’s ESRD Clinical Performance Measure Advisory Panel, a panelist for the American Kidney Fund’s African-American Early Kidney Disease Program, and a member of the Medical Advisory Board of the American Association of Kidney Patients. Dr. Owen is the recipient of several local and national awards for patient advocacy and care. As the recipient of several research grants from the National Institute of Diabetes, Digestive, and Kidney Disease, and the Agency for Health Care Policy Research, Dr. Owen is an active clinical and translational science investigator and has authored numerous original reports, chapters, and editorials.

Jimmy Roberts, MD, FACP (Work Group Vice-Chair), is a nephrologist working in private practice in Chico, California. Dr. Roberts served as Chairman of the Renal Physicians Association Working Committee on Clinical Practice Guidelines and editor of the Clinical Practice Guideline on Adequacy of Hemodialysis, published in 1993. He is Past President of the Renal Physicians Association and served on the RPA Board of Directors from 1986-1998. Dr. Roberts is an Adjunct Professor of Biology at California State University in Chico, Medical Director of the Chico Dialysis Center in Chico, and an attending physician at Enloe Medical Center. Dr. Roberts is past chairman of the Board of Directors of the Transpacific ESRD Network (#17). He is actively involved in CQI programs for ESRD dialysis and transplant patients. During his career, Dr. Roberts has written more than 75 research articles, book chapters, abstracts, and letters to the editor, and has made kidney-related presentations at more than 40 scientific meetings.

Steven Alexander, MD, FAAP, is Professor of Pediatrics/Chief, Pediatric Nephrology at Stanford University Medical Center and Director of Dialysis Department/ Medical Director of Kidney Transplantation at Lucile Packard Children’s Hospital. He has worked with ESRD patients for over 20 years. Dr. Alexander also serves as a Pediatric Nephrology Representative for the Health Care Financing Administrations ESRD Medical Review Criteria Expert Panel, and is a former member of the Board of Directors for the American Kidney Fund and the Renal Physicians Association. He has written more than 100 publications and is on the Editorial Board for Peritoneal Dialysis International and Advances in Renal Replacement Therapy.

David Cohen, MD, PhD, is Chief of the Renal Section at the West Palm Beach VA. In addition to his dialysis-related duties, Dr. Cohen is Chair of the Ethics Committee at the West Palm Beach VA. He is an active member of the American College of Physicians, American Society of Nephrology, and American Society of Transplant Physicians. Dr. Cohen has performed home hemodialysis on himself since 1984.

William Harmon, MD, is Chief, Division of Nephrology at the Childrens Hospital and an Associate Professor of Pediatrics at Harvard Medical School. Dr. Harmon has been involved in multiple studies designed to provide optimal treatment for children with end-stage renal disease, including both dialysis and renal transplantation. He is an active member of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) and has been instrumental in developing the dialysis component of that registry. He has been active in several professional societies; he is the past chairman of the NKF Pediatric Nephrology/Urology Council, served on the Board of Directors of UNOS, and is a member of the council of the American Society of Transplant Physicians.

Todd Ing, MB, FRCP(C), FRCP, FACP, joined the Hines Veterans Affairs Hospital as a nephrologist and the Loyola University Chicago Stritch School of Medicine as a faculty member in 1976, after a number of years in private practice. Committed to medical education, he is an editor of the Handbook of Dialysis. Topics of special interest to him include the formulation of dialysates, bicarbonate-buffered peritoneal dialysis, the first-use syndrome, peritoneal sclerosis, peritoneal fluid eosinophilia, dialysis ascites, and dialysis-associated pericarditis.

Judith Kari, MSW, LICSW, works for the Health Care Financing Administration. Ms. Kari has been working for more than 25 years to improve outcomes for ESRD patients. Her experience includes direct clinical work, research and evaluation, and work for the government and an ESRD Network. She has served as a consultant to industry and has also worked with the Egyptian government on ESRD program issues. Ms. Kari has been active in many professional societies and has served on the Board of Directors for the National Kidney Foundation.

Marcia Keen, PhD, MS, RN, is Senior Manager, Nephrology professional Services at Amgen Inc. She has been actively involved in dialysis patient care and clinical research for a number of years. Her research interests have included quantification techniques for hemodialysis and peritoneal dialysis therapy, anticoagulation control in hemodialysis, and vascular access. Her published work includes book chapters and research reports in a number of professional journals. She is a member of the Steering Committee for the National Institutes of Health-sponsored HEMO trial. She was a member of the writing committee for the RPA Clinical Practice Guideline on Adequacy of Hemodialysis. She completed her doctorate at the University of California, San Francisco, in volume and osmolity control in hemodialysis patients.

Karren King, MSW, ACSW, LCSW, is a nephrology social work consultant. Previously, she was Program coordinator for the Missouri Kidney Program, where she was responsible for directing its patient education program for western Missouri for 9 years. Prior to this, she worked as a nephrology social worker for 11 years in both dialysis and kidney transplantation. Ms. King has published articles on various psycho-social aspects of kidney disease, including adherence, patient education, and rehabilitation. She is co-author of the National Kidney Foundation’s Initiation or Withdrawal of Dialysis in End Stage Renal Disease: Guidelines for the Health Care Team. She also was a member of the working group that developed the Renal Physicians Association and American Society of Nephrology’s Clinical Practice Guidelines on Shared Decision-Making in the Appropriate Initiation of and Withdrawal from Dialysis. Ms. King is a past national President of the Council of Nephrology Social Workers and previously served on the Board of Directors and Executive Committee of the National Kidney Foundation. She also chaired its Patients Services Committee.

Joseph Letteri, MD, is Professor of Clinical Medicine, Health Sciences Center, School of Medicine, for the State University of New York at Stony Brook in Stony Brook, New York. Dr. Letteri is also President of South Shore Renal Physicians, P.C., in Syosset, New York. He has treated ESRD patients for over 30 years and received multiple awards from the National Kidney Foundation for his work in the field, including the Presidents Award (1993), Distinguished Service Award (1990), and Hoenig Award (1987). Dr. Letteri has written more than 60 nephrology articles, and is on the editorial board of Mineral and Electrolyte Metabolism, American Journal of Nephrology, Advances in Renal Replacement Therapy, and Journal of Nephrology.

A. Peter Lundin, MD, FACP, is Medical Director of the Kings County Hospital Center Ambulatory Hemodialysis Unit and Professor of Clinical Medicine at the State University of New York, Health Science Center at Brooklyn, New York. Dr. Lundin was a hemodialysis patient for 25 years, had been a transplant patient for 5 years, and is back on hemodialysis for the past 4 years. He served as President of the American Association of Kidney Patients. He has worked with the Health Care Financing Administration on quality assurance projects. He is involved in the teaching of medical students, residents and fellows. Dr. Lundin’s current interests include quality of life and improvement of functional activity for dialysis and transplant patients. He reported an affiliation with Brooklyn Home Dialysis Training Center.

Anthony Messana, BSc, has been active within the kidney community since 1978 in the clinical, technical, and administrative areas. Mr. Messana served as President of the National Renal Administrators Association in 1991 and has worked with many other kidney community groups and associations. He has written and spoken extensively on reimbursement and operational issues for facilities and on policy and reimbursement issues related to the End-Stage Renal Disease Program.

Jean Nardini, MSN, is the Patient Care Director of the Hemodialysis Units for the Massachusetts General Hospital in Boston, Massachusetts. Ms. Nardini has been working to improve outcomes for ESRD patients for more than 25 years. She is involved with numerous professional groups. She is currently serving as President of the ANNA, is a member of the board of directors for the ESRD Network of New England, serving as its secretary since 1994, and has been an active member of the Regional Council of Nurse Nephrology Administrators for nearly 20 years.

Keith Norris, MD, is the Vice Chair of the Department of Medicine and Director of the Clinical Research Center at the Charles R. Drew University of Medicine and Science in Los Angeles, California. He serves as a CQI and QA advisor to industry. He has over 50 publications and currently is active in research focusing on renal osteodystrophy, hypertensive kidney disease, and ESRD among minority populations. He is active in many professional societies and is the immediate Past President of the Association of Minority Nephrologists.

Gigi Politoski has more than 19 years of experience in non-profit public relations and program development. She is the current Director, Program Division of the National Kidney Foundation, Inc., in New York City. Ms. Politoski oversees the development and implementation of professional and patient education programs for the NKF in the areas of early intervention and prevention, end-stage renal disease, and organ donation and transplantation. Prior to her current position, Ms. Politoski was Communications/Marketing Director for the Foundation, a position she held since 1986. Active in many committees and boards in the kidney community, Ms. Politoski has written several articles and abstracts related to organ donation and the needs of donor families. She was also instrumental in overseeing the development of professional and patient implementation programs and resources for the NKF-K/DOQI guidelines.

 

 

 


© 2001 National Kidney Foundation, Inc

web version created by cyberNephrologyTM and The Nephron Information Center